Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrien Kuipers

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
FEBS Open Bio|September 19, 2024
YAP-TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escapeRoberto Alva-Ruiz, Ryan D Watkins, Jennifer L Tomlinson, et al.
Journal of Hepatology|March 8, 2024
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinomaJennifer L Tomlinson, Binbin Li, Jingchun Yang, et al.
Annals of Surgical Oncology|March 17, 2019
Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational StudyJudith E K R Hentzen, Koen P Rovers, Hendrien Kuipers, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 29, 2020
Should jaundice preclude resection in patients with gallbladder cancer? Results from a nation-wide cohort studyElise A J de Savornin Lohman, Hendrien Kuipers, Mike van Dooren, et al.
Hepatology (Baltimore, Md.)|February 10, 2025
Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma modelsMincheng Yu, Jack W Sample, Irene K Yan, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinomaHendrien Kuipers, Danielle M Carlson, Erik Jessen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 14, 2022
Long-term follow-up of a randomized trial of biliary drainage in perihilar cholangiocarcinomaLynn E Nooijen, Stijn Franssen, Carlijn I Buis, et al.
BJS Open|April 9, 2023
Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort studyFrederik J H Hoogwater, Hendrien Kuipers, Vincent E de Meijer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2026
Outcomes of Liver Transplant Versus Partial Hepatectomy for Perihilar Cholangiocarcinoma Patients Requiring Arterial ReconstructionEdoardo Poletto, Pim B Olthof, Andrea Ruzzenente, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
FEBS Open Bio|September 19, 2024
YAP-TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escapeRoberto Alva-Ruiz, Ryan D Watkins, Jennifer L Tomlinson, et al.
Journal of Hepatology|March 8, 2024
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinomaJennifer L Tomlinson, Binbin Li, Jingchun Yang, et al.
Annals of Surgical Oncology|March 17, 2019
Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational StudyJudith E K R Hentzen, Koen P Rovers, Hendrien Kuipers, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 29, 2020
Should jaundice preclude resection in patients with gallbladder cancer? Results from a nation-wide cohort studyElise A J de Savornin Lohman, Hendrien Kuipers, Mike van Dooren, et al.
Hepatology (Baltimore, Md.)|February 10, 2025
Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma modelsMincheng Yu, Jack W Sample, Irene K Yan, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinomaHendrien Kuipers, Danielle M Carlson, Erik Jessen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 14, 2022
Long-term follow-up of a randomized trial of biliary drainage in perihilar cholangiocarcinomaLynn E Nooijen, Stijn Franssen, Carlijn I Buis, et al.
BJS Open|April 9, 2023
Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort studyFrederik J H Hoogwater, Hendrien Kuipers, Vincent E de Meijer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2026
Outcomes of Liver Transplant Versus Partial Hepatectomy for Perihilar Cholangiocarcinoma Patients Requiring Arterial ReconstructionEdoardo Poletto, Pim B Olthof, Andrea Ruzzenente, et al.
Pageof 2